CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.37% | 2.07% | 209.29% | 118.29% | 983.51% |
| Total Depreciation and Amortization | 1.19% | 1.86% | 0.57% | -1.25% | 0.58% |
| Total Amortization of Deferred Charges | 2.56% | -11.13% | -6.66% | -6.64% | -6.57% |
| Total Other Non-Cash Items | 872.18% | 855.23% | -303.34% | -107.26% | -82.71% |
| Change in Net Operating Assets | 105.49% | -520.64% | -33.53% | 57.86% | 66.03% |
| Cash from Operations | 42.63% | -23.15% | 11.00% | 62.36% | 856.98% |
| Capital Expenditure | -85.70% | 16.79% | 36.61% | 20.73% | 52.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.93% | 16.79% | 36.61% | 35.07% | 52.16% |
| Total Debt Issued | -34.65% | -16.67% | -20.99% | 29.11% | 46.82% |
| Total Debt Repaid | 24.12% | 15.45% | 20.66% | -25.68% | -45.12% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.44% | -0.46% | -0.29% | -0.79% | -0.90% |
| Other Financing Activities | 71.59% | 29.52% | -827.95% | -205.33% | -1,197.26% |
| Cash from Financing | -66.91% | 13.10% | -4.30% | -122.80% | -418.02% |
| Foreign Exchange rate Adjustments | 259.65% | -319.22% | 175.88% | -20,466.67% | -269.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.35% | -125.72% | 261.64% | -468.24% | 490.48% |